Home2359 • HKG
add
WuXi AppTec Ord Shs H
Previous close
$112.40
Day range
$102.80 - $108.70
Year range
$44.30 - $124.70
Market cap
318.26B HKD
Avg Volume
7.05M
P/E ratio
20.80
Dividend yield
1.36%
In the news
Financials
Income Statement
Revenue
Net income
| (CNY) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 11.14B | 32.01% |
Operating expense | — | — |
Net income | — | — |
Net profit margin | — | — |
Earnings per share | 1.02 | 22.89% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 25.16B | 71.50% |
Total assets | 83.82B | 12.67% |
Total liabilities | 23.41B | 21.30% |
Total equity | 60.41B | — |
Shares outstanding | 3.43B | — |
Price to book | 6.44 | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
| (CNY) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | — | — |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
WuXi AppTec Co., Ltd. is a Chinese provider of contract research, development, and manufacturing, services for the pharmaceutical and life-sciences industry, headquartered in Shanghai, China. The company operates research and manufacturing facilities in Asia, North America, and Europe.
The company is listed in mainland China and Hong Kong. Its H‑shares are constituents of the Hang Seng Index, and its A‑shares are included in the FTSE China A50 Index.
Founded in 2000 by chemist Ge Li as WuXi PharmaTech, the company expanded through acquisitions and re‑listings in 2018 after a 2015 take‑private. Wikipedia
Founded
Dec 1, 2000
Website
Employees
37,832
